Summary
Global Market Direct’s pharmaceuticals report, “Eastern Cooperative Oncology Group – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable). It also gives a complete picture of the institute’s future therapy areas of focus.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, primary and secondary research using institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together with in-house analysis, by Global Markets Direct’s team of industry experts.
Scope
- Review of therapeutics under development by Eastern Cooperative Oncology Group.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, for the pharmaceutical markets across the globe.
- Product profiles for late stage and clinical stage products of Eastern Cooperative Oncology Group with complete description of the product’s developmental history, mechanism of action, clinical trials, major milestones and others.
- Recent updates of Eastern Cooperative Oncology Group’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.
Reasons to buy
- Identify new drug targets and therapeutic classes in Eastern Cooperative Oncology Group’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate Eastern Cooperative Oncology Group’s position with total access to a detailed intelligence on its therapeutic products development.
- Assess the growth potential of Eastern Cooperative Oncology Group in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with Eastern Cooperative Oncology Group.
- Avoid Intellectual Property Rights related issues.
- Undertake deals with an understanding of the mergers and partnerships that have shaped the sector.
Global Market Direct’s pharmaceuticals report, “Eastern Cooperative Oncology Group – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable). It also gives a complete picture of the institute’s future therapy areas of focus.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, primary and secondary research using institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together with in-house analysis, by Global Markets Direct’s team of industry experts.
Scope
- Review of therapeutics under development by Eastern Cooperative Oncology Group.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, for the pharmaceutical markets across the globe.
- Product profiles for late stage and clinical stage products of Eastern Cooperative Oncology Group with complete description of the product’s developmental history, mechanism of action, clinical trials, major milestones and others.
- Recent updates of Eastern Cooperative Oncology Group’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.
Reasons to buy
- Identify new drug targets and therapeutic classes in Eastern Cooperative Oncology Group’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate Eastern Cooperative Oncology Group’s position with total access to a detailed intelligence on its therapeutic products development.
- Assess the growth potential of Eastern Cooperative Oncology Group in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with Eastern Cooperative Oncology Group.
- Avoid Intellectual Property Rights related issues.
- Undertake deals with an understanding of the mergers and partnerships that have shaped the sector.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 list of Figures
2 INTRODUCTION
3 EASTERN COOPERATIVE ONCOLOGY GROUP - RESEARCH AND DEVELOPMENT OVERVIEW
3.1 Key Therapeutic Areas
4 EASTERN COOPERATIVE ONCOLOGY GROUP - INVESTIGATIONAL PRODUCTS REVIEW
4.1 Products by Stage of Development
4.2 Products - Monotherapy
4.3 Products - Combination Treatment Modalities
5 EASTERN COOPERATIVE ONCOLOGY GROUP - INVESTIGATIONAL PRODUCTS GLANCE
5.1 Eastern Cooperative Oncology Group - Phase III Products
5.2 Eastern Cooperative Oncology Group - Phase II Products
5.3 Eastern Cooperative Oncology Group - Phase I Products
5.4 Eastern Cooperative Oncology Group - Pre-Clinical and Discovery Products
6 EASTERN COOPERATIVE ONCOLOGY GROUP - DRUG PROFILES
6.1 Product 1 - Product Profile
6.1.1 Product Description
6.1.2 Mechanism of Action
6.1.3 R&D Progress
7 EASTERN COOPERATIVE ONCOLOGY GROUP - INVESTIGATIONAL PRODUCTS ANALYSIS
7.1 Eastern Cooperative Oncology Group Products by Therapeutic Class
7.2 Eastern Cooperative Oncology Group Products by Target
7.3 Eastern Cooperative Oncology Group by Route of Administration
7.4 Eastern Cooperative Oncology Group Products by Molecule Type
8 EASTERN COOPERATIVE ONCOLOGY GROUP - RECENT PRODUCT UPDATES
9 EASTERN COOPERATIVE ONCOLOGY GROUP - FEATURED NEWS
10 EASTERN COOPERATIVE ONCOLOGY GROUP - LOCATIONS
11 APPENDIX
11.1 Global Markets Direct Research Methodology
11.2 Coverage
11.3 Secondary Research
11.4 Primary Research
11.5 Models
11.6 Expert Panels
11.7 Contact Us
11.8 Disclaimer
LIST OF TABLES
Table 1: Eastern Cooperative Oncology Group - Key Therapeutic Areas
Table 2: Eastern Cooperative Oncology Group - Products by Stage of Development,
Table 3: Eastern Cooperative Oncology Group - Monotherapy Products under Investigation,
Table 4: Eastern Cooperative Oncology Group - Combination Treatment Modalities under Investigation,
Table 5: Eastern Cooperative Oncology Group - Phase III Products,
Table 6: Eastern Cooperative Oncology Group - Phase II Products,
Table 7: Eastern Cooperative Oncology Group - Phase I Products,
Table 8: Eastern Cooperative Oncology Group - Pre-Clinical and Discovery Products,
Table 9: Eastern Cooperative Oncology Group - Products By Therapeutic Class
Table 10: Eastern Cooperative Oncology Group - Products By Target
Table 11: Eastern Cooperative Oncology Group - Products By Route of Administration
Table 12: Eastern Cooperative Oncology Group - Products By Molecule Type
Table 13: Eastern Cooperative Oncology Group - Recent Product Updates
LIST OF FIGURES
Figure 1: Eastern Cooperative Oncology Group - Research and Development Overview
Figure 2: Eastern Cooperative Oncology Group - Products by Stage of Development,
Figure 3: Eastern Cooperative Oncology Group - Monotherapy Products,
Figure 4: Eastern Cooperative Oncology Group - Combination Treatment Modalities,
Figure 5: Eastern Cooperative Oncology Group - Products By Therapeutic Class and Stage of Development
Figure 6: Eastern Cooperative Oncology Group - Products By Therapeutic Class
Figure 7: Eastern Cooperative Oncology Group - Products By Target and Stage of Development
Figure 8: Eastern Cooperative Oncology Group - Products By Target
Figure 9: Eastern Cooperative Oncology Group - Products By Route of Administration and Stage of Development
Figure 10: Eastern Cooperative Oncology Group - Products By Route of Administration
Figure 11: Eastern Cooperative Oncology Group - Products By Molecule Type and Stage of Development
Figure 12: Eastern Cooperative Oncology Group - Products By Molecule Type
COMPANIES MENTIONED
Eastern Cooperative Oncology Group
1.1 List of Tables
1.2 list of Figures
2 INTRODUCTION
3 EASTERN COOPERATIVE ONCOLOGY GROUP - RESEARCH AND DEVELOPMENT OVERVIEW
3.1 Key Therapeutic Areas
4 EASTERN COOPERATIVE ONCOLOGY GROUP - INVESTIGATIONAL PRODUCTS REVIEW
4.1 Products by Stage of Development
4.2 Products - Monotherapy
4.3 Products - Combination Treatment Modalities
5 EASTERN COOPERATIVE ONCOLOGY GROUP - INVESTIGATIONAL PRODUCTS GLANCE
5.1 Eastern Cooperative Oncology Group - Phase III Products
5.2 Eastern Cooperative Oncology Group - Phase II Products
5.3 Eastern Cooperative Oncology Group - Phase I Products
5.4 Eastern Cooperative Oncology Group - Pre-Clinical and Discovery Products
6 EASTERN COOPERATIVE ONCOLOGY GROUP - DRUG PROFILES
6.1 Product 1 - Product Profile
6.1.1 Product Description
6.1.2 Mechanism of Action
6.1.3 R&D Progress
7 EASTERN COOPERATIVE ONCOLOGY GROUP - INVESTIGATIONAL PRODUCTS ANALYSIS
7.1 Eastern Cooperative Oncology Group Products by Therapeutic Class
7.2 Eastern Cooperative Oncology Group Products by Target
7.3 Eastern Cooperative Oncology Group by Route of Administration
7.4 Eastern Cooperative Oncology Group Products by Molecule Type
8 EASTERN COOPERATIVE ONCOLOGY GROUP - RECENT PRODUCT UPDATES
9 EASTERN COOPERATIVE ONCOLOGY GROUP - FEATURED NEWS
10 EASTERN COOPERATIVE ONCOLOGY GROUP - LOCATIONS
11 APPENDIX
11.1 Global Markets Direct Research Methodology
11.2 Coverage
11.3 Secondary Research
11.4 Primary Research
11.5 Models
11.6 Expert Panels
11.7 Contact Us
11.8 Disclaimer
LIST OF TABLES
Table 1: Eastern Cooperative Oncology Group - Key Therapeutic Areas
Table 2: Eastern Cooperative Oncology Group - Products by Stage of Development,
Table 3: Eastern Cooperative Oncology Group - Monotherapy Products under Investigation,
Table 4: Eastern Cooperative Oncology Group - Combination Treatment Modalities under Investigation,
Table 5: Eastern Cooperative Oncology Group - Phase III Products,
Table 6: Eastern Cooperative Oncology Group - Phase II Products,
Table 7: Eastern Cooperative Oncology Group - Phase I Products,
Table 8: Eastern Cooperative Oncology Group - Pre-Clinical and Discovery Products,
Table 9: Eastern Cooperative Oncology Group - Products By Therapeutic Class
Table 10: Eastern Cooperative Oncology Group - Products By Target
Table 11: Eastern Cooperative Oncology Group - Products By Route of Administration
Table 12: Eastern Cooperative Oncology Group - Products By Molecule Type
Table 13: Eastern Cooperative Oncology Group - Recent Product Updates
LIST OF FIGURES
Figure 1: Eastern Cooperative Oncology Group - Research and Development Overview
Figure 2: Eastern Cooperative Oncology Group - Products by Stage of Development,
Figure 3: Eastern Cooperative Oncology Group - Monotherapy Products,
Figure 4: Eastern Cooperative Oncology Group - Combination Treatment Modalities,
Figure 5: Eastern Cooperative Oncology Group - Products By Therapeutic Class and Stage of Development
Figure 6: Eastern Cooperative Oncology Group - Products By Therapeutic Class
Figure 7: Eastern Cooperative Oncology Group - Products By Target and Stage of Development
Figure 8: Eastern Cooperative Oncology Group - Products By Target
Figure 9: Eastern Cooperative Oncology Group - Products By Route of Administration and Stage of Development
Figure 10: Eastern Cooperative Oncology Group - Products By Route of Administration
Figure 11: Eastern Cooperative Oncology Group - Products By Molecule Type and Stage of Development
Figure 12: Eastern Cooperative Oncology Group - Products By Molecule Type
COMPANIES MENTIONED
Eastern Cooperative Oncology Group
